PragmaClin is developing novel approaches to managing neurological diseases.
Traditional healthcare delivery is in a disrupted state.
Decentralized or virtual models have taken center stage according to a recent study. Patient visits can be performed in the home through video, while data is collected remotely via sensors and biowearables. Clinicians and investigators are adopting technology to reduce in-person, on-site visits and to assess a patient’s status in real-time using secure digital evaluation tools.
What We Do
PragmaClin aims to help patients with Parkinson's disease monitor their condition with the use of our flagship software, PRIMS. We want a world where patients can get help faster, with more accurate results.
Our Growth, Over the Years
2020
PragmaClin becomes Incorporated
Over $190,000 in pitch competition wins
2021-22
Received over $1 million in non-dilutive funding.
Future
Helping patients around the world
Our Partners
Join us in innovating our healthcare system.
We want to hear from you! If you have any questions about our company or want to get involved, let us know.